Drug Information

General Information
Drug ID
DR01371
Drug Name
9-Aminocamptothecin
Synonyms
IDEC-132; (S)-10-Amino-4-ethyl-4-hydroxy-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14-dione; 9-Amino-20(S)-camptothecin
Drug Type
Small molecular drug
Indication Ovarian cancer [ICD11:2C73] Phase 2 [1]
Structure
3D MOL 2D MOL
Formula
C20H17N3O4
Canonical SMILES
CCC1(C2=C(COC1=O)C(=O)N3CC4=CC5=C(C=CC=C5N=C4C3=C2)N)O
InChI
InChI=1S/C20H17N3O4/c1-2-20(26)13-7-16-17-10(6-11-14(21)4-3-5-15(11)22-17)8-23(16)18(24)12(13)9-27-19(20)25/h3-7,26H,2,8-9,21H2,1H3/t20-/m0/s1
InChIKey
FUXVKZWTXQUGMW-FQEVSTJZSA-N
CAS Number
CAS 91421-43-1
Pharmaceutical Properties Molecular Weight 363.4 Topological Polar Surface Area 106
Heavy Atom Count 27 Rotatable Bond Count 1
Hydrogen Bond Donor Count 2 Hydrogen Bond Acceptor Count 6
XLogP
0.3
PubChem CID
72402
PubChem SID
483848 ,600881 ,8195177 ,11408968 ,12014702 ,14876953 ,14876954 ,26725257 ,43128571 ,50028358 ,57318699 ,77695393 ,87560557 ,96023346 ,99373552 ,99432308 ,103073229 ,103082936 ,103170467 ,103910998 ,103922005 ,104352855 ,117586313 ,119525751 ,124796287 ,124953919 ,127347071 ,127903358 ,135030378 ,137138142 ,142371086 ,152036014 ,152227690 ,160809182 ,162179182 ,162937855 ,163374696 ,164758081 ,170559265 ,172860100 ,174531450 ,178115205 ,179151428 ,184538696 ,188900245 ,198973567 ,223445740 ,223603491 ,225031198 ,226414396
ChEBI ID
CHEBI:80755
TTD Drug ID
D07UHX
DT(s) Transporting This Drug BCRP Transporter Info Breast cancer resistance protein Substrate [2]
References
1 ClinicalTrials.gov (NCT00001427) A Phase II Trial of 72-Hour Continuous IV Infusion of 9-Aminocamptothecin With G-CSF Support in Patients With Advanced Ovarian Cancer Previously Treated With Paclitaxel and Cisplatin
2 Pharmacogenomic importance of ABCG2. Pharmacogenomics. 2008 Aug;9(8):1005-9.

If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.